Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID‐19) infection. Issue 2 (1st April 2020)

• Record Type: Journal Article
• Authors: Chen, Dunjin; Yang, Huixia; Cao, Yun; Cheng, Weiwei; Duan, Tao; Fan, Cuifang; Fan, Shangrong; Feng, Ling; Gao, Yuanmei; He, Fang; He, Jing; Hu, Yali; Jiang, Yi; Li, Yimin; Li, Jiafu; Li, Xiaotian; Li, Xuelan; Lin, Kangguang; Liu, Caixia; Liu, Juntao; Liu, Xinghui; Pan, Xingfei; Pang, Qiumei; Pu, Meihua; Qi, Hongbo; Shi, Chunyan; Sun, Yu; Sun, Jingxia; Wang, Xietong; Wang, Yichun; Wang, Zilian; Wang, Zhijian; Wang, Chen; Wu, Suqiu; Xin, Hong; Yan, Jianying; Zhao, Yangyu; Zheng, Jun; Zhou, Yihua; Zou, Li; Zeng, Yingchun; Zhang, Yuanzhen; Guan, Xiaoming;
• Is Part Of: International journal of gynaecology and obstetrics. Volume 149:Issue 2(2020)
• Page Start: 130
• Page End: 136
• Publication Date: 2020-04-01
• Subjects: COVID‐19 -- Expert consensus -- Management guidelines -- Neonates -- Pregnant women; Gynecology -- Periodicals; Obstetrics -- Periodicals; Electronic journals; 618
• DOI: 10.1002/ijgo.13146
• Languages: English
• ISSNs: 0020-7292

Abstract

Abstract: Objective: To provide clinical management guidelines for novel coronavirus (COVID‐19) in pregnancy. Methods: On February 5, 2020, a multidisciplinary teleconference comprising Chinese physicians and researchers was held and medical management strategies of COVID‐19 infection in pregnancy were discussed. Results: Ten key recommendations were provided for the management of COVID‐19 infections in pregnancy. Conclusion: Currently, there is no clear evidence regarding optimal delivery timing, the safety of vaginal delivery, or whether cesarean delivery prevents vertical transmission at the time of delivery; therefore, route of delivery and delivery timing should be individualized based on obstetrical indications and maternal–fetal status. Abstract : Currently, there is no clear evidence regarding optimal delivery timing or route of delivery for pregnant women with COVID‐19 infection; these should be individualized based on obstetrical indications and maternal–fetal status.